Comparative Pharmacology of the 3 Marketed Dual Orexin Antagonists—Daridorexant, Lemborexant, and Suvorexant—Part 2. Principal Drug Metabolizing Enzyme, Drug-Drug Interactions, and Effects of Liver and Renal Impairment on Metabolism
用户emSTjtF7m7Oc
1个月前
92
10
已完结
1. 系统已在2026-03-16 12:30:15对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1097/pra.0000000000000690
文献链接: https://journals.lww.com/10.1097/PRA.0000000000000690
其他信息:
出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Sheldon H. Preskorn
